Notifications
10 minutes, 49 seconds
-23 Views 0 Comments 0 Likes 0 Reviews
Digital breast tomosynthesis (DBT), commonly referred to as 3D mammography, is an advanced imaging technology used for breast cancer detection. It produces multiple layered images of breast tissue, allowing radiologists to identify tumors more accurately compared to traditional 2D mammography.
The digital breast tomosynthesis market size was valued at USD 3.29 billion in 2025 and is projected to reach USD 11.78 billion by 2035, expanding at a compound annual growth rate (CAGR) of 13.60% between 2026 and 2035.
| Market Metric | Value |
|---|---|
| Market Size (2025) | USD 3.29 Billion |
| Forecast Market Size (2035) | USD 11.78 Billion |
| CAGR (2026–2035) | 13.60% |
| Dominant Region | North America |
| Fastest Growing Region | Asia Pacific |
| Key Technology | 3D Mammography |
The increasing prevalence of breast cancer, combined with rising demand for early detection technologies and improvements in diagnostic imaging systems, is driving strong growth in the digital breast tomosynthesis market worldwide.
Rising global breast cancer cases are increasing demand for advanced screening technologies.
3D mammography improves tumor detection accuracy compared to traditional mammography.
Hospitals and diagnostic imaging centers are rapidly adopting digital breast tomosynthesis systems.
Government screening programs are expanding the adoption of breast imaging technologies.
Technological innovations such as AI-assisted imaging are improving diagnostic efficiency.
Breast cancer remains one of the most frequently diagnosed cancers worldwide. Early detection significantly improves survival rates, making advanced diagnostic imaging technologies essential in modern healthcare systems.
Digital breast tomosynthesis enables radiologists to view breast tissue layer by layer, improving tumor visibility and reducing overlapping tissue effects.
Healthcare providers are increasingly transitioning from conventional mammography systems to digital breast tomosynthesis platforms due to improved imaging accuracy and enhanced clinical outcomes.
Benefits of digital breast tomosynthesis include:
Improved cancer detection rates
Reduced false positives
Lower patient recall rates
Enhanced visualization of dense breast tissue
These advantages have accelerated the adoption of DBT systems across hospitals and diagnostic imaging centers.
Government and healthcare organizations across developed and emerging regions are expanding population-based breast cancer screening initiatives.
These screening programs require reliable, high-throughput imaging systems capable of delivering accurate diagnostic results, which makes digital breast tomosynthesis a preferred technology.
2D/3D combination systems integrate traditional digital mammography with tomosynthesis imaging capabilities within a single device.
These systems enable healthcare providers to obtain both 2D and 3D images during a single scan, improving diagnostic efficiency and reducing patient exposure to additional imaging procedures.
Key benefits include:
Enhanced cancer detection accuracy
Reduced recall rates
Efficient clinical workflow
Compatibility with existing mammography systems
As a result, 2D/3D combination systems represent a major share of the digital breast tomosynthesis market.
Standalone digital breast tomosynthesis systems are designed exclusively for high-resolution 3D imaging.
These systems are commonly deployed in:
Specialized breast imaging centers
High-volume screening facilities
Research institutions
Standalone systems provide detailed tissue visualization and improved lesion detection, making them valuable for advanced diagnostic procedures.
Hospitals represent the largest end-user segment within the digital breast tomosynthesis market.
Many healthcare institutions are establishing dedicated breast imaging departments equipped with advanced diagnostic technologies to support early cancer detection and treatment planning.
Independent diagnostic centers are rapidly adopting digital breast tomosynthesis systems to offer high-quality outpatient screening services.
These centers provide cost-effective imaging services and faster appointment availability compared to hospital settings.
Additional applications include:
Mobile breast screening units
Research and academic institutions
Specialty breast health clinics
The expansion of mobile screening programs is particularly important in improving access to early detection services in rural and underserved regions.
North America currently dominates the digital breast tomosynthesis market due to strong healthcare infrastructure and widespread adoption of advanced medical imaging technologies.
Key growth factors include:
High breast cancer screening rates
Favorable reimbursement policies
Early adoption of 3D mammography technologies
Presence of leading medical imaging manufacturers
The United States accounts for the largest market share in the region.
Europe represents a significant portion of the global digital breast tomosynthesis market.
Growth is supported by:
Government-supported breast cancer screening programs
Increasing healthcare investments
Rising adoption of digital imaging technologies
Countries such as Germany, the United Kingdom, and France are major contributors to the regional market.
Asia Pacific is projected to experience the fastest market growth during the forecast period.
Factors driving regional expansion include:
Increasing breast cancer awareness
Rapidly expanding healthcare infrastructure
Growing adoption of advanced diagnostic technologies
Government initiatives to improve cancer screening programs
China, India, and Japan are key markets within the region.
These regions are gradually adopting digital breast tomosynthesis technologies due to increasing awareness of early cancer detection and improvements in healthcare infrastructure.
Although adoption rates remain lower compared to developed regions, the market is expected to grow steadily in the coming years.
Several technological and clinical trends are shaping the future of breast imaging:
Integration of artificial intelligence in breast imaging analysis
Growing demand for AI-assisted diagnostic systems
Increasing adoption of high-resolution 3D mammography
Development of faster image reconstruction technologies
Expansion of mobile breast screening programs
These advancements are improving diagnostic accuracy while reducing imaging time and operational costs.
The global digital breast tomosynthesis market is highly competitive and characterized by continuous innovation and technological advancement.
Major companies operating in the market include:
Hologic, Inc.
Varex Imaging Corporation
GE Healthcare
Siemens Healthineers AG
Fujifilm Corporation
PerkinElmer Inc.
These organizations focus on product innovation, strategic collaborations, and investments in research and development to strengthen their market presence and expand global distribution networks.
Digital breast tomosynthesis is a 3D mammography imaging technology that captures multiple X-ray images of the breast from different angles to create layered images, enabling more accurate detection of breast cancer.
The global digital breast tomosynthesis market was valued at USD 3.29 billion in 2025 and is expected to reach USD 11.78 billion by 2035, growing at a CAGR of 13.60%.
The market is primarily dominated by 2D/3D combination systems and standalone 3D tomosynthesis systems, with combination systems being widely adopted for routine breast cancer screening.
The Asia Pacific region is expected to witness the fastest growth due to expanding healthcare infrastructure and increasing breast cancer screening programs.
The primary applications include hospitals, diagnostic imaging centers, mobile screening programs, and specialty breast clinics.
About Us
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.
Our high-quality, data-driven analysis provides the essential framework for organizations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organization remains agile, proactive, and poised for success in today's competitive market.
Don't miss the opportunity to elevate your business intelligence and strengthen your strategic planning. Secure your organization's future success by acquiring one of our Expert Market Research reports today.
Media Contact
Company Name: Claight Corporation
Contact Person: Deepanshu Choudhary, Business Consultant
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
Author name- Deepanshu Choudhary
Digital Breast Tomosynthesis Market Digital Breast Tomosynthesis Market Size Digital Breast Tomosynthesis Market Trend
